MSKCC Oncologic Toxicity Management Symposium A Multidisciplinary Approach 2024
Include: 24 videos 20 pdfs, size: 7.26 GB
Information:Date & Location
Thursday, June 20, 2024, 8:00 AM – 5:00 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY
Memorial Sloan Kettering’s 2024 Oncologic Toxicity Management (OTM) Symposium represents a cutting-edge, multidisciplinary approach to managing adverse events associated with modern oncology treatments. The increasing complexity of these treatments, coupled with the influence of genetic, biological, and environmental factors on toxicities, has made effective management a significant challenge. OTM employs advanced tools and techniques to identify individual differences and create personalized treatment plans. By offering evidence-based and tailored treatments for adverse events based on each patient’s unique needs, this program aims to minimize the risk of additional toxicity. This approach contributes to improved quality of life, reduced morbidity, and consistent dosing of cancer therapies.
During this one-day, in-person Symposium, participants will have the opportunity to learn from and interact with experts at the forefront of OTM interventions. The program features a keynote presentation and didactic sessions covering OTM from bench to bedside. Each session will conclude with an interactive panel Q& A with the expert faculty.
The OTM Symposium will cover a diverse range of topics, including:
- Updates on Current Adverse Events Specific-Biological Targeted Therapies
- The Role of Diet, Exercise, CBD, and Cannabis
- Sexual Health, Psychosocial Health, and Fertility
- Case Discussions on Challenging Cases of Patients with a Prior History of Autoimmune Disease and Treatment with Immune Checkpoint Inhibitors
The Symposium aims to provide crucial insights into the mechanisms underlying these adverse events, offering opportunities for intervention and personalized patient care.
Who Should Attend
This Symposium is intended for Physicians, Physician Assistants, Nurse Practitioners, Registered Nurses, Pharmacists, and other healthcare professionals treating cancer patients and their associated symptoms.
- Evaluate new personalized strategies for preventing and managing treatment related toxicities
- Promote the translation of research findings into clinical practice
- Discuss non-pharmacological interventions for prevention of toxicities
Topics:
Dietary Recommendation for Management of Oncologic Toxicities.mp4
Dietary Recommendation for Management of Oncologic Toxicities.pdf
Eczema and Psoriasis and Immune Checkpoint Inhibitors.mp4
Eczema and Psoriasis and Immune Checkpoint Inhibitors.pdf
Fertility Preservation.mp4
Fertility Preservation.pdf
Genomic Biomar.mp4
Genomic Biomar.pdf
Inflammatory Bowel Disease and Immune Checkpoint Inhibitors.mp4
Inflammatory Bowel Disease and Immune Checkpoint Inhibitors.pdf
Management of Cardiovascular Adverse Events.mp4
Management of Cardiovascular Adverse Events.pdf
Management of Dermatologic Adverse Events.mp4
Management of Dermatologic Adverse Events.pdf
Management of Endocrinologic Adverse Events.mp4
Management of Endocrinologic Adverse Events.pdf
Management of Gastrointestinal Adverse Events.mp4
Management of Gastrointestinal Adverse Events.pdf
Management of Neurologic Adverse Events.mp4
Management of Neurologic Adverse Events.pdf
Management of Rheumatologic Adverse Events.mp4
Management of Rheumatologic Adverse Events.pdf
OTMsymposium2024_Brochure.pdf
Panel Discussion and Q&A I.mp4
Panel Discussion and Q&A II.mp4
Panel Discussion and Q&A III.mp4
Panel Discussion and Q&A IV.mp4
Panel Discussion and Q&A V.mp4
Psychosocial Health – Body Imaging and Feeling Like Yourself Again.mp4
Psychosocial Health – Body Imaging and Feeling Like Yourself Again.pdf
Psychosocial Health – Coping with the Side Effects of Treatment.mp4
Psychosocial Health – Coping with the Side Effects of Treatment.pdf
Rheumatoid Arthritis and Immune Checkpoint Inhibitors.mp4
Rheumatoid Arthritis and Immune Checkpoint Inhibitors.pdf
Role of CBD Cannabis for Management of Oncologic Toxicities.mp4
Role of CBD Cannabis for Management of Oncologic Toxicities.pdf
Role of Exercise for Management of Oncologic Toxicities.mp4
Role of Exercise for Management of Oncologic Toxicities.pdf
Sexual Dysfunction in Men.mp4
Sexual Dysfunction in Men.pdf
Sexual Dysfunction in Women.mp4
Sexual Dysfunction in Women.pdf
Solid Organ Transplant and Immune Checkpoint Inhibitors.mp4
Solid Organ Transplant and Immune Checkpoint Inhibitors.pdf
Related products
